Fennec Pharmaceuticals Inc (FENC) — Cash Flow-to-Debt Ratio
Fennec Pharmaceuticals Inc (FENC) has a Cash Flow-to-Debt Ratio of 0.07x as of March 2026, meaning its operating cash flow of $2.38 Million could theoretically repay 0% of its total liabilities ($34.15 Million) in one year. Check FENC cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Fennec Pharmaceuticals Inc Cash Flow-to-Debt Ratio (1999–2025)
Historical debt coverage capacity for Fennec Pharmaceuticals Inc across 26 annual periods. Also explore how large is Fennec Pharmaceuticals Inc's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Fennec Pharmaceuticals Inc (1999–2025)
Year-by-year debt coverage analysis for Fennec Pharmaceuticals Inc. For market capitalisation and broader financial context, see Fennec Pharmaceuticals Inc (FENC) total market value.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.36x | $-12.47 Million | $35.02 Million | ▼ -167.1% |
| 2024 | 0.53x | $26.98 Million | $50.82 Million | ▲ +219.2% |
| 2023 | -0.45x | $-17.14 Million | $38.49 Million | ▲ +27.2% |
| 2022 | -0.61x | $-18.06 Million | $29.51 Million | ▲ +71.4% |
| 2021 | -2.14x | $-14.22 Million | $6.64 Million | ▲ +67.8% |
| 2020 | -6.64x | $-15.60 Million | $2.35 Million | ▼ -66.6% |
| 2019 | -3.99x | $-9.06 Million | $2.27 Million | ▲ +16.6% |
| 2018 | -4.78x | $-7.83 Million | $1.64 Million | ▼ -115.9% |
| 2017 | -2.21x | $-3.64 Million | $1.64 Million | ▲ +58.1% |
| 2016 | -5.28x | $-2.12 Million | $402.00K | ▼ -33.7% |
| 2015 | -3.95x | $-1.86 Million | $471.00K | ▼ -309.3% |
| 2014 | -0.97x | $-1.70 Million | $1.76 Million | ▼ -40.2% |
| 2013 | -0.69x | $-2.21 Million | $3.21 Million | ▼ -68.5% |
| 2012 | -0.41x | $-2.99 Million | $7.32 Million | ▲ +30.7% |
| 2011 | -0.59x | $-3.23 Million | $5.47 Million | ▼ -233.9% |
| 2010 | -0.18x | $-1.93 Million | $10.92 Million | ▲ +98.4% |
| 2009 | -10.98x | $-4.69 Million | $427.00K | ▼ -205.5% |
| 2008 | -3.59x | $-10.81 Million | $3.01 Million | ▲ +17.3% |
| 2007 | -4.35x | $-13.30 Million | $3.06 Million | ▼ -190.2% |
| 2006 | -1.50x | $-13.47 Million | $9.00 Million | ▼ -2.4% |
| 2005 | -1.46x | $-12.26 Million | $8.39 Million | ▼ -113.1% |
| 2003 | -0.69x | $-5.99 Million | $8.73 Million | ▼ -30.7% |
| 2002 | -0.52x | $-5.43 Million | $10.35 Million | ▲ +88.0% |
| 2001 | -4.39x | $-3.23 Million | $736.04K | ▼ -3.7% |
| 2000 | -4.23x | $-2.69 Million | $635.41K | ▼ -106.2% |
| 1999 | -2.05x | $-1.22 Million | $596.46K | — |